Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / FAMAR Group, GE HealthCare Sign...
Business contract manufacturing agreement

FAMAR Group, GE HealthCare Sign Manufacturing Deal

Analysis based on 6 articles · First reported May 19, 2026 · Last updated May 19, 2026

Sentiment
60
Attention
4
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The agreement between Famar and GE HealthCare is expected to positively impact both companies. Famar will expand its manufacturing capabilities and market presence, while GE HealthCare will enhance its supply chain resilience and meet increasing demand for contrast media in Europe.

Pharmaceuticals Healthcare
Event Summary

Famar, a European pharmaceutical Contract Development and Manufacturing Organization (CDMO), has signed a contract manufacturing agreement with GE HealthCare. This agreement involves Famar filling and finishing vials of GE HealthCare's iodine-based contrast media at its newly acquired Homburg site in Germany. Commercial supply is slated to begin in 2028, with the Homburg site aiming to provide up to 25 million patient doses annually into GE HealthCare's supply network by 2031. This collaboration will enable GE HealthCare to expand its manufacturing capacity for European customers and increase the resiliency of its supply network. Famar acquired the Homburg site from MiP Pharma in September 2025 and plans to develop it into a multi-customer CDMO platform, strengthening its capabilities in aseptic and lyophilized fill & finish.

Key Actions
100 Famar signed agreement GE HealthCare
90 GE HealthCare expanded manufacturing capacity
80 Famar acquired site MiP Pharma
Entities Involved
priv
Famar
Famar has signed a contract manufacturing agreement with GE HealthCare, expanding its capabilities and strengthening its footprint in high-value dosage forms at its Homburg site.
Importance 90 Sentiment 70
stock
GE HealthCare
GE HealthCare has entered into a contract manufacturing agreement with Famar to expand its manufacturing capacity for iodine-based contrast media for European customers, increasing supply network resiliency.
Importance 90 Sentiment 60
per
Riku Rautsola
Riku Rautsola, CEO of Famar, expressed pride in working with GE HealthCare and developing the Homburg site.
Importance 30 Sentiment 0
per
François Roche
François Roche, General Manager, EMEA, for GE HealthCare's Pharmaceutical Diagnostics segment, highlighted the agreement's role in scaling production capacity and increasing network resiliency.
Importance 30 Sentiment 0
cnt
Germany
The Homburg site, located in Germany, is where Famar will conduct the contract manufacturing for GE HealthCare.
Importance 20 Sentiment 0
priv
MiP Pharma
Famar acquired the Homburg site from MiP Pharma in September 2025, which is now being developed into a multi-customer CDMO platform.
Importance 10 Sentiment 0
cnt
Norway
GE HealthCare sources active pharmaceutical ingredients from its Lindesnes facility in Norway.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.